🇺🇸 FDA
Pipeline program

bromocriptine

199/11754

Phase 2 small_molecule on_hold

Quick answer

bromocriptine for Stereotyped Behavior is a Phase 2 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Stereotyped Behavior
Phase
Phase 2
Modality
small_molecule
Status
on_hold

Clinical trials